Posology for Regenerative Therapy.
作者信息
Terzic Andre, Behfar Atta
机构信息
From the Department of Cardiovascular Medicine and Department of Molecular Pharmacology and Experimental Therapeutics, Center for Regenerative Medicine, Mayo Clinic, Rochester, MN.
出版信息
Circ Res. 2017 Nov 10;121(11):1213-1215. doi: 10.1161/CIRCRESAHA.117.312074.
Abstract
摘要
相似文献
1
Posology for Regenerative Therapy.再生疗法的剂量学
Circ Res. 2017 Nov 10;121(11):1213-1215. doi: 10.1161/CIRCRESAHA.117.312074.
2
New frontiers in regenerative medicine in cardiology: the potential of Wharton's jelly mesenchymal stem cells.心血管再生医学的新前沿：牙髓间质干细胞的潜力。
Curr Stem Cell Res Ther. 2013 Jan;8(1):39-45. doi: 10.2174/1574888x11308010006.
3
Mesenchymal Stem Cells as a Biological Drug for Heart Disease: Where Are We With Cardiac Cell-Based Therapy?间充质干细胞作为治疗心脏病的生物药物：基于细胞的心脏治疗进展如何？
Circ Res. 2015 Jul 17;117(3):229-33. doi: 10.1161/CIRCRESAHA.117.306306.
4
Advanced measurement techniques of regional myocardial function to assess the effects of cardiac regenerative therapy in different models of ischaemic cardiomyopathy.评估不同类型缺血性心肌病中心脏再生治疗效果的区域性心肌功能的先进测量技术。
Eur Heart J Cardiovasc Imaging. 2012 Oct;13(10):808-18. doi: 10.1093/ehjci/jes119. Epub 2012 Jun 15.
5
Cell Spray Transplantation of Stem Cells for Ischemic Cardiomyopathy-How Effective Are Dispersed Droplets?用于缺血性心肌病的干细胞细胞喷雾移植——分散液滴的效果如何？
Transplantation. 2018 Dec;102(12):1972-1973. doi: 10.1097/TP.0000000000002386.
6
Mesenchymal Stem Cell Therapy for Ischemic Heart Disease: Advances and Challenges.间充质干细胞治疗缺血性心脏病：进展与挑战。
Curr Pharm Des. 2018;24(26):3132-3142. doi: 10.2174/1381612824666180913151059.
7
Critical path in cardiac stem cell therapy: an update on cell delivery.心脏干细胞治疗中的关键路径：细胞递送的最新进展。
Cytotherapy. 2013 Apr;15(4):399-415. doi: 10.1016/j.jcyt.2012.11.003. Epub 2013 Jan 5.
8
Mesenchymal stem cell-derived extracellular vesicles: novel frontiers in regenerative medicine.间质干细胞衍生的细胞外囊泡：再生医学的新前沿。
Stem Cell Res Ther. 2018 Mar 9;9(1):63. doi: 10.1186/s13287-018-0791-7.
9
Immunomodulation Is the Key to Cardiac Repair.免疫调节是心脏修复的关键。
Circ Res. 2017 May 12;120(10):1530-1532. doi: 10.1161/CIRCRESAHA.117.310954.
10
Mesenchymal Stem Cell Therapy in Osteoarthritis and Regenerative Medicine.间充质干细胞疗法在骨关节炎与再生医学中的应用
Curr Sports Med Rep. 2018 Dec;17(12):441-443. doi: 10.1249/JSR.0000000000000541.
引用本文的文献
1
Mass Customized Outlook for Regenerative Heart Failure Care.再生心力衰竭治疗的大规模定制展望。
Int J Mol Sci. 2021 Oct 22;22(21):11394. doi: 10.3390/ijms222111394.
2
Stem cell therapy for dilated cardiomyopathy.干细胞治疗扩张型心肌病。
Cochrane Database Syst Rev. 2021 Jul 21;7(7):CD013433. doi: 10.1002/14651858.CD013433.pub2.
3
Regenerative medicine clinical readiness.再生医学临床准备就绪。
Regen Med. 2021 Mar;16(3):309-322. doi: 10.2217/rme-2020-0178. Epub 2021 Feb 24.
4
Scientific Papers and Patents on Substances with Unproven Effects. Part 2.关于效果未经证实物质的科学论文与专利。第2部分。
Recent Pat Drug Deliv Formul. 2019;13(3):160-173. doi: 10.2174/1872211313666190819124752.
5
Clinical Experience With Regenerative Therapy in Heart Failure: Advancing Care With Cardiopoietic Stem Cell Interventions.心力衰竭再生治疗的临床经验：通过心脏发生干细胞干预推进治疗。
Circ Res. 2018 May 11;122(10):1344-1346. doi: 10.1161/CIRCRESAHA.118.312753.
本文引用的文献
1
Make regeneration great again; stronger together.
Eur Heart J. 2017 Apr 14;38(15):1094-1095. doi: 10.1093/eurheartj/ehx151.
2
Dose Comparison Study of Allogeneic Mesenchymal Stem Cells in Patients With Ischemic Cardiomyopathy (The TRIDENT Study).缺血性心肌病患者同种异体间充质干细胞剂量比较研究（三叉戟研究）
Circ Res. 2017 Nov 10;121(11):1279-1290. doi: 10.1161/CIRCRESAHA.117.311827. Epub 2017 Sep 18.
3
Advanced Methods for Dose and Regimen Finding During Drug Development: Summary of the EMA/EFPIA Workshop on Dose Finding (London 4-5 December 2014).药物研发期间剂量和给药方案确定的先进方法：欧洲药品管理局/欧洲制药工业协会联合会剂量确定研讨会总结（2014年12月4 - 5日，伦敦）
CPT Pharmacometrics Syst Pharmacol. 2017 Jul;6(7):418-429. doi: 10.1002/psp4.12196. Epub 2017 Jul 19.
4
Benefit of cardiopoietic mesenchymal stem cell therapy on left ventricular remodelling: results from the Congestive Heart Failure Cardiopoietic Regenerative Therapy (CHART-1) study.心源性间充质干细胞治疗对左心室重构的益处：充血性心力衰竭心源性再生治疗（CHART-1）研究的结果。
Eur J Heart Fail. 2017 Nov;19(11):1520-1529. doi: 10.1002/ejhf.898. Epub 2017 May 31.
5
Cardiopoietic cell therapy for advanced ischaemic heart failure: results at 39 weeks of the prospective, randomized, double blind, sham-controlled CHART-1 clinical trial.用于晚期缺血性心力衰竭的心肌生成细胞疗法：前瞻性、随机、双盲、假手术对照的CHART-1临床试验39周结果
Eur Heart J. 2017 Mar 1;38(9):648-660. doi: 10.1093/eurheartj/ehw543.
6
Clarifying Stem-Cell Therapy's Benefits and Risks.阐明干细胞疗法的益处与风险。
N Engl J Med. 2017 Mar 16;376(11):1007-1009. doi: 10.1056/NEJMp1613723. Epub 2016 Nov 30.
7
CardioPulse: Regenerative medicine in the practice of cardiology.《心脏脉搏：心脏病学实践中的再生医学》
Eur Heart J. 2016 Apr 7;37(14):1089-90.
8
Clinical development plan for regenerative therapy in heart failure.心力衰竭再生治疗的临床开发计划。
Eur J Heart Fail. 2016 Feb;18(2):142-4. doi: 10.1002/ejhf.479. Epub 2016 Jan 21.
9
Concise Review: Review and Perspective of Cell Dosage and Routes of Administration From Preclinical and Clinical Studies of Stem Cell Therapy for Heart Disease.简明综述：心脏病干细胞治疗的临床前和临床研究中细胞剂量及给药途径的综述与展望
Stem Cells Transl Med. 2016 Feb;5(2):186-91. doi: 10.5966/sctm.2015-0101. Epub 2015 Dec 18.
10
Repetition rescues regenerative reserve.重复可挽救再生储备。
Eur Heart J. 2016 Jun 1;37(21):1667-70. doi: 10.1093/eurheartj/ehv596. Epub 2015 Dec 5.
Zotero 插件